Are omics technologies going to impact the management of periodontal and peri-implant diseases in the future?
The use of omics technologies is changings our understanding of the interactions between the human body and the microorganisms in our body. From the “colonization” to the “holobiont” concept, this has also impacted the classical infections, that are interpreted better today with the dysbiosis approach. The vast amount of information that omics are producing needs to be adequately digested and cautiously interpreted, with a reasonable expectation of being helpful in the prevention and therapy and periodontal and peri-implant diseases. New options, based on personalized-medicine, should be developed and tested, once preventive and therapeutic targets are identified.
Prof. David Herrera is Dean, Chair of Periodontology, and Full Professor at the Faculty of Odontology, Complutense University of Madrid (UCM), Spain. He is also Co-Director of the UCM Graduate Program in Periodontology and Co-Director of the UCM ETEP Research Group (Etiology and Therapy of Periodontal and Peri-implant Diseases).
His scientific work focuses on periodontal and peri-implant diseases, with particular interest in etiology, therapy, microbiology, and antimicrobials. Prof. Herrera has authored more than 200 scientific publications in peer-reviewed JCR journals.
